Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00201266 · ClinicalTrials.gov registry record
Histoblood Group Antigens as a Risk Factor of Asthma
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 126
- Enrollment target
NCT00201266 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 126 participants.
The verdict
NCT00201266 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This study will evaluate the link between blood group antigens and asthma exacerbations.
Interventions
- PROCEDURE Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2005-07 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00201266
The ClinicalTrials.gov registry entry for NCT00201266 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Screening is the first listed.
NCT00201266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00201266 about?
NCT00201266 is a clinical study titled "Histoblood Group Antigens as a Risk Factor of Asthma". This study will evaluate the link between blood group antigens and asthma exacerbations.
What is the current status of trial NCT00201266?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2005-07. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00201266?
The interventions under investigation include: Screening (PROCEDURE).
Who is sponsoring clinical trial NCT00201266?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.